Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02143492 · ClinicalTrials.gov registry record
Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC
A clinical trial, sponsored by Argos Therapeutics.
- Completed
- Registry status
- 11
- Enrollment target
NCT02143492 is a clinical trial that has completed, run by Argos Therapeutics. The registered enrollment target is 11 participants.
The verdict
NCT02143492 has completed, sponsored by Argos Therapeutics.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Standard treatment for kidney cancer is to remove the tumors from the body with surgery. The purpose of this clinical trial is to collect, preserve, and store excess kidney cancer tumor specimens that would normally be discarded after surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02143492
The ClinicalTrials.gov registry entry for NCT02143492 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Argos Therapeutics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02143492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02143492 about?
NCT02143492 is a clinical study titled "Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC". Standard treatment for kidney cancer is to remove the tumors from the body with surgery. The purpose of this clinical trial is to collect, preserve, and store excess kidney cancer tumor specimens that would normally be discarded after surgery.
What is the current status of trial NCT02143492?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2013-08. Estimated completion is 2015-07.
Who is sponsoring clinical trial NCT02143492?
This trial is sponsored by Argos Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.